Relation between TAFI gene polymorphisms, the risk of coronary heart disease and plasma TAFI levels in the PRIME Study: use of a new ELISA independent of the Thr325Ile polymorphism

被引：0
|
作者：
机构：
来源：
GENETIC EPIDEMIOLOGY | 2004年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：287 / 288
页数：2
相关论文
共 11 条
  • [1] Thr325Ile polymorphism of the TAFI gene is related to TAFI antigen plasma levels and angiographic restenosis after percutaneous coronary interventions
    Segev, A
    Hegele, RA
    Lau, HK
    Sparkes, JD
    Teitel, JM
    Chisholm, RJ
    Strauss, BH
    THROMBOSIS RESEARCH, 2004, 114 (02) : 137 - 141
  • [2] Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction
    Morange, PE
    Henry, M
    Frere, C
    Juhan-Vague, I
    BLOOD, 2002, 99 (05) : 1878 - 1879
  • [3] TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study
    Morange, PE
    Tregouet, DA
    Frere, C
    Luc, G
    Arveiler, D
    Ferrieres, J
    Amouyel, P
    Evans, A
    Ducimetiere, P
    Cambien, F
    Tiret, L
    Juhan-Vague, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) : 1503 - 1510
  • [4] Association between the Thr-325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease
    Verdu, Jose
    Marco, Pascual
    Benlloch, Susana
    Lucas, Javier
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2008, 14 (04) : 494 - 495
  • [5] Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity
    Hamdy, Mona
    Shaheen, Iman A.
    Khallaf, Mohamed
    Selim, Yasmeen M. M.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (06)
  • [6] The Thr325Ile polymorphism and intrinsic enzymatic activity of proCPU (TAFI): New pitfalls interfering with straightforward proCPU activity measurement in plasma.
    Willemse, J.
    Hendriks, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 203 - 203
  • [7] Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2, and risk of coronary heart disease: Results from a large case-control study
    Khuseyinova, N
    Rothenbacher, D
    Hoffmann, MM
    Brenner, H
    Koenig, W
    CIRCULATION, 2006, 113 (08) : E322 - E322
  • [8] The 2756A>G variant in the gene encoding methionine synthase:: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study
    Klerk, M
    Lievers, KJA
    Kluijtmans, LAJ
    Blom, HJ
    den Heijer, M
    Schouten, EG
    Kok, FJ
    Verhoef, P
    THROMBOSIS RESEARCH, 2003, 110 (2-3) : 87 - 91
  • [9] Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2 and risk of coronary heart disease. Results from a large case-control study
    Khuseyinova, N.
    Rothenbacher, D.
    Hoffmann, M.
    Brenner, H.
    Koenig, W.
    EUROPEAN HEART JOURNAL, 2006, 27 : 129 - 129
  • [10] A new T-287C polymorphism in the 5′ regulatory region of the tissue factor pathway inhibitor gene -: Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels
    Moatti, D
    Haidar, B
    Fumeron, F
    Gauci, L
    Boudvillain, O
    Seknadji, P
    Ollivier, V
    Aumont, MC
    de Prost, D
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (02) : 244 - 249
12